Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma

Selma Bekri, PhD, Reunet Rodney-Sandy, BS, Diana Gruenstein, BS, Bjarne Bogen, MD PhD, Daniel Levey, PhD, Hearn Jay Cho, MD

Blood (2018) 132 (Supplement 1): 1947.

https://doi.org/10.1182/blood-2018-99-117129

Published: 2018

Journal Articles

Generation of BCR-ABL Reactive CD4+ T Helper Cells By Reprograming and Redifferentiation

Norihiro Ueda, MD, Yasusi Uemura, PhD, Rhong Zhang, MD PhD, Shuichi Kitayama, Yutaka Yasui, Minako Tatsumi, Tian-Yi Liu, MD PhD, Kiyotaka Kuzushima, MD PhD, Hitoshi Kiyoi, MD PhD, Tomoki Naoe, MD PhD, Shin Kaneko, MD PhD

Blood (2015) 126 (23): 3424.

https://doi.org/10.1182/blood.V126.23.3424.3424

Published: 2015

Journal Articles

Lmo2 Induces T-Cell Leukemia with Epigenetic Deregulation of CD4.

Susan Cleveland, Utpal P. Dave, MD

Blood (2008) 112 (11): 3361.

https://doi.org/10.1182/blood.V112.11.3361.3361

Published: 2008

Journal Articles

Zanolimumab (HuMax-CD4™), a Fully Human Monoclonal Antibody: Efficacy and Safety in Patients with Relapsed or Treatment-Refractory Non-Cutaneous CD4 + T-Cell Lymphoma.

Francesco d’Amore, MD, John Radford, MD, Mats Jerkeman, MD, Thomas Relander, MD, Herve Tilly, MD, Anders Osterborg, MD, Franck Morschhauser, MD, Martin Gramatzki, MD, Martin Dreyling, MD, Bo Bang, MD, Ole Baadsgaard, MD, Hans Hagberg, MD

Blood (2007) 110 (11): 3409.

https://doi.org/10.1182/blood.V110.11.3409.3409

Published: 2007

Journal Articles

Zanolimumab, a Fully Human Monoclonal Antibody: Preliminary Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphomas (PTCL).

Francesco d’Amore, MD, Thomas Relander, M.D., Mats Jerkeman, M.D., Hans Hagberg, M.D., Anders Osterborg, M.D., Peter Johnson, M.D., John A. Radford, M.D., Barry W. Hancock, M.D., Martin Gramatzki, M.D., Norbert Schmitz, M.D., Herve Tilly, M.D, Franck Morschhauser, M.D., STeen Lisby, M.D, Ole Baadsgaard, M.D

Blood (2006) 108 (11): 2723.

https://doi.org/10.1182/blood.V108.11.2723.2723

Published: 2006

Journal Articles

Zanolimumab, a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in Patients with CD4 + Mycosis Fungoides (MF) Type CTCL (Stage IB-IVB) Who Are Refractory or Intolerant to Targretin and One Other Standard Therapy.

Madeleine Duvic, MD, Youn Kim, M.D., Neil J. Korman, M.D., Erin Boh, M.D., Adam Lerner, M.D., Michael P. Heffernan, M.D., Kenneth B. Hymes, M.D., Theresa Pacheco, M.D., Craig A. Elmets, M.D., Steen Lisby, M.D., Ole Baadsgaard, M.D.

Blood (2006) 108 (11): 2731.

https://doi.org/10.1182/blood.V108.11.2731.2731

Published: 2006

Journal Articles

Hsp90 Is Critical for the Regulation of Human T Lymphocytes and NK Cell Phenotype and Function.

Jooeun Bae, PhD, Constantine Mitsiades, M.D., Rao Prabhala Prabhala, PhD, Tai Yu-Tzu, PhD, Jeff Martinson, BS, Steven Hartson, PhD, Teru Hideshima, PhD, Lawrence Catley, M.D., Xianfeng Li, BS, Ramesh Babu Batchu, PhD, Robert Bertheau, BS, Shammas Masood, PhD, Sushima Samala, M.S., Jeff Miller, PhD, Kenneth Anderson, M.D., Nikhil Munshi, M.D.

Blood (2005) 106 (11): 3464.

https://doi.org/10.1182/blood.V106.11.3464.3464

Published: 2005

Journal Articles

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Francesco d’Amore, T. Relander, H. Hagberg, A. Osterborg, M. Hansen, L. Moeller, P. Johnson, J. Radford, B. Hancock, M. Gramatzki, S. Krause, M. Dreyling, N. Schmitz, S. Lisby, O. Baadsgaard

Blood (2005) 106 (11): 3354.

https://doi.org/10.1182/blood.V106.11.3354.3354

Published: 2005

Journal Articles

Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice

Sébastien Maury, Benoı̂t Salomon, David Klatzmann, José L. Cohen

Blood (2001) 98 (10): 3156–3158.

https://doi.org/10.1182/blood.V98.10.3156

Published: 2001

Journal Articles

Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4

Ewa Bryl, Magdalena Gazda, Jerzy Foerster, Jacek M. Witkowski

Blood (2001) 98 (4): 1100–1107.

https://doi.org/10.1182/blood.V98.4.1100

Published: 2001

Journal Articles

Lineage-Specific Expression of Human Immunodeficiency Virus (HIV) Receptor/Coreceptors in Differentiating Hematopoietic Precursors: Correlation With Susceptibility to T- and M-Tropic HIV and Chemokine-Mediated HIV Resistance

C. Chelucci, I. Casella, M. Federico, U. Testa, G. Macioce, E. Pelosi, R. Guerriero, G. Mariani, A. Giampaolo, H.J. Hassan, C. Peschle

Blood (1999) 94 (5): 1590–1600.

https://doi.org/10.1182/blood.V94.5.1590

Published: 1999

Journal Articles

CD4 Cross-Linking (CD4XL) Induces RAS Activation and Tumor Necrosis Factor-α Secretion in CD4 + T Cells

Seetha M. Lakshmi Tamma, Narendra Chirmule, Hirosuka Yagura, Naoki Oyaizu, Vaniambadi Kalyanaraman, Savita Pahwa

Blood (1997) 90 (4): 1588–1593.

https://doi.org/10.1182/blood.V90.4.1588

Published: 1997

Journal Articles

Human Immunodeficiency Virus (HIV)-Resistant CD4 + UT-7 Megakaryocytic Human Cell Line Becomes Highly HIV-1 and HIV-2 Susceptible Upon CXCR4 Transfection: Induction of Cell Differentiation by HIV-1 Infection

Marta Baiocchi, Eleonora Olivetta, Cristiana Chelucci, Anna Claudia Santarcangelo, Roberta Bona, Paola d'Aloja, Ugo Testa, Norio Komatsu, Paola Verani, Maurizio Federico

Blood (1997) 89 (8): 2670–2678.

https://doi.org/10.1182/blood.V89.8.2670

Published: 1997

Journal Articles

A Synthetic CD4-CDR3 Peptide Analog Enhances Bone Marrow Engraftment Across Major Histocompatibility Barriers

Ute Koch, Robert Korngold

Blood (1997) 89 (8): 2880–2890.

https://doi.org/10.1182/blood.V89.8.2880

Published: 1997

Journal Articles

Phenotypic and Functional Evidence for the Expression of CD4 by Hematopoietic Stem Cells Isolated From Human Fetal Liver

Marcus O. Muench, Maria Grazia Roncarolo, Reiko Namikawa

Blood (1997) 89 (4): 1364–1375.

https://doi.org/10.1182/blood.V89.4.1364

Published: 1997

Journal Articles

Characterization of peripheral blood stem cells in mice

Y Yamamoto, R Yasumizu, Y Amou, N Watanabe, N Nishio, J Toki, S Fukuhara, S Ikehara

Blood (1996) 88 (2): 445–454.

https://doi.org/10.1182/blood.V88.2.445.bloodjournal882445

Published: 1996

Journal Articles

Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells

JA Sosman, KR Oettel, SD Smith, JA Hank, P Fisch, PM Sondel

Blood (1990) 75 (10): 2005–2016.

https://doi.org/10.1182/blood.V75.10.2005.2005

Published: 1990

NARROW

Mechanisms of CD4 T Cell Tumor Immunity in a Preclinical Model of Multiple Myeloma

Generation of BCR-ABL Reactive CD4+ T Helper Cells By Reprograming and Redifferentiation

Lmo2 Induces T-Cell Leukemia with Epigenetic Deregulation of CD4.

Zanolimumab (HuMax-CD4™), a Fully Human Monoclonal Antibody: Efficacy and Safety in Patients with Relapsed or Treatment-Refractory Non-Cutaneous CD4 + T-Cell Lymphoma.

Zanolimumab, a Fully Human Monoclonal Antibody: Preliminary Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphomas (PTCL).

Zanolimumab, a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in Patients with CD4 + Mycosis Fungoides (MF) Type CTCL (Stage IB-IVB) Who Are Refractory or Intolerant to Targretin and One Other Standard Therapy.

Hsp90 Is Critical for the Regulation of Human T Lymphocytes and NK Cell Phenotype and Function.

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice

Age-related increase of frequency of a new, phenotypically distinct subpopulation of human peripheral blood T cells expressing lowered levels of CD4

Lineage-Specific Expression of Human Immunodeficiency Virus (HIV) Receptor/Coreceptors in Differentiating Hematopoietic Precursors: Correlation With Susceptibility to T- and M-Tropic HIV and Chemokine-Mediated HIV Resistance

CD4 Cross-Linking (CD4XL) Induces RAS Activation and Tumor Necrosis Factor-α Secretion in CD4 + T Cells

Human Immunodeficiency Virus (HIV)-Resistant CD4 + UT-7 Megakaryocytic Human Cell Line Becomes Highly HIV-1 and HIV-2 Susceptible Upon CXCR4 Transfection: Induction of Cell Differentiation by HIV-1 Infection

A Synthetic CD4-CDR3 Peptide Analog Enhances Bone Marrow Engraftment Across Major Histocompatibility Barriers

Phenotypic and Functional Evidence for the Expression of CD4 by Hematopoietic Stem Cells Isolated From Human Fetal Liver

Characterization of peripheral blood stem cells in mice

Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only